Dabrafenib,Navitoclax,Trametinib
Novartis,AbbVie
['navitoclax', 'trametinib', 'dabrafenib', 'melanoma']
#etctn results coming soon at #asco23! (9466), testing the addition of navitoclax to the combination of dabrafenib and trametinib in people who have braf mutant melanoma , presented by dr. zeynep eroglu of (june 5 at 3:24 pm 3:36 pm cdt). 
Official Twitter account of NCI's Cancer Therapy Evaluation Program, providing updates to our trials research community. Part of @NIH. Privacy: https://t.co/9Aox3geiD8